OriGene Technologies, Inc.

Industry

  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Large Molecule
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Contract Research Organization-CRO
  • Services
See more in Biomedtracker

Latest on OriGene Technologies, Inc.

Medtech Insight

Medical Device Deals Update, October 2015

Strategic Transactions

In Vivo

Deals Shaping The Medical Industry, October 2015

IN VITRO DIAGNOSTICS Mergers & Acquisitions Erba Diagnostics Mannheim GMBH Lumora Ltd. Clinical testing products developer ERBA Diagnostics Mannheim GMBH bought private molecular diagnostics firm

Scrip

Investors Focus On Devices, Services In China, But Drug R&D Still Has Some Attraction

 
• By Brian Yang

BEIJING – Healthcare-related investment in China reached nearly $2 billion last year with a noted focus on medical devices and clinical services along with mobile technology, according to Zero2IPO ,

In Vivo

Deals In Depth: April 2013

Exhibit 1 Top Alliances In April 2013 *Potential Deal Value is the sum of up-front fees plus disclosed pre-commercialization money. Elsevier’s Strategic Transactions Exhibit 2 Top Mergers & Acquisitio